Please provide your email address to receive an email when new articles are posted on . Since the widespread availability of Descemet's stripping endothelial keratoplasty, have you noticed how much ...

Please provide your email address to receive an email when new articles are posted on . Given the results achieved so far, I would (and do) recommend Descemet’s stripping for Fuchs’ dystrophy. In my ...

Add Yahoo as a preferred source to see more of our stories on Google. In 1910, Professor Ernst Fuchs, an Austrian ophthalmologist, published an article describing 13 patients with Fuchs’ dystrophy, a ...

A newer technique for preparing corneal tissue for transplantation has been shown to be safe and effective, while providing a faster and smoother process than the traditional technique, according to ...

Bottom Line: Researchers discovered three novel genetic mutations associated with Fuchs endothelial corneal dystrophy, the most common corneal disorder requiring transplantation. Journal in Which the ...

INDIANAPOLIS--(BUSINESS WIRE)--Price Vision Group announced today that it is the first site to initiate patient treatment in a clinical trial evaluating use of an experimental drug treatment in ...

Design Therapeutics is set to present significant safety findings from its Phase 1 trial of DT-168, highlighting progress in their clinical development for treating Fuchs endothelial corneal dystrophy ...

A corneal dystrophy is a condition in which one or more parts of the cornea lose their normal clarity because of a buildup of cloudy material. There are over 20 corneal dystrophies that affect all ...

Fuchs' corneal dystrophy is one of the most common eye diseases diagnosed in almost 5% of the population of Europe aged 40 years or over. It is a hereditary eye disease that causes vision impairment ...

Researchers discovered three novel genetic mutations associated with Fuchs endothelial corneal dystrophy, the most common corneal disorder requiring transplantation. Researchers discovered three novel ...